Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001604801-25-000003
Filing Date
2025-07-10
Accepted
2025-07-10 14:03:40
Documents
1
Effectiveness Date
2025-07-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10181
  Complete submission text file 0001604801-25-000003.txt   11395
Mailing Address 2401 RESEARCH BLVD, SUITE 205 FORT COLLINS CO 80526
Business Address 2401 RESEARCH BLVD, SUITE 205 FORT COLLINS CO 80526 970-295-4373
Armis Biopharma, Inc. (Filer) CIK: 0001604801 (see all company filings)

EIN.: 841445770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-551277 | Film No.: 251115848